Age-related changes in tau expression in transgenic mouse model of amyotrophic lateral sclerosis

Neurochemical Research

Volumn 32, Issue 3, 2007, Pages 415-421

  Barańczyk Kuźma, Anna ^a   Usarek, Ewa ^a   Kuźma Kozakiewcz, Magdalena ^a   Kaźmierczak, Beata ^a   Gajewska, Beata ^a   Schwalenstocker, Birgit ^b   Ludolph, Albert C ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Age; Alternative splicing; Amyotrophic lateral sclerosis; Central nervous system; Tau expression; Transgenic mice

Indexed keywords

MESSENGER RNA; TAU PROTEIN;

AGE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; EXON; GENE MUTATION; HIPPOCAMPUS; MALE; MOTONEURON; MOUSE; NERVE DEGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SPINAL CORD; TRANSGENIC MOUSE;

AGING; ALTERNATIVE SPLICING; ANIMALS; CEREBELLUM; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURON DISEASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TAU PROTEINS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 33847122118     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9242-4     Document Type: Article

References (24)

1. Rowland LP (ed) (1995) Hereditary and acquired motor neuron diseases, in Merritt's textbook of neurology. Williams & Wilkins, Baltimore, pp 742-749
2. Mulder DW, Kurland LT, Offord KP, Beard CM (1986) Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36:511-517
3. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772-1775
4. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72:1858-1862
5. Schoenfeld TA, Obar RA (1994) Diverse distribution and function of fibrous microtubule-associated proteins in the nervous system. Int Rev Cytol 151:67-137
6. Chin SS, Goldman JE (1996) Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 55:499-508
7. Andreadis A, Brown WM, Kosik KS (1992) Structure and novel exons of the human tau gene. Biochemistry 31:10626-10633
8. Lee G, Neve RL, Kosik KS (1989) The microtubule binding domain of tau protein. Neuron 2:1615-1624
9. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705
10. Usarek E, Kuzma-Kozakiewicz M, Schwalenstocker B, Kazmierczak B, Munch C, Ludolph AC, Baranczyk-Kuzma A (2006) Tau isoforms expression in transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res 31:597-602
11. Wang J, Xu G, Borchelt DR (2002) High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol Dis 9:139-148
12. Gurney ME (1997) The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci 152(Suppl 1):67-73
13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
14. Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762:1051-1067
15. Morrison BM, Shu IW, Wilcox AL, Gordon JW, Morrison JH (2000) Early and selective pathology of light chain neurofilament in the spinal cord and sciatic nerve of G86R mutant superoxide dismutase transgenic mice. Exp Neurol 165(2):207-220
16. Andrus PK, Fleck TJ, Gurney ME, Hall ED (1998) Protein oxidative damage in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 71:2041-2048
17. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM (1996). Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 93:3155-3160
18. Kiernan JA, Hudson AJ (1993) Changes in shapes of surviving motor neurons in amyotrophic lateral sclerosis. Brain 116(Pt 1):203-215
19. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price Dl, Cleveland DW(1997)ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-338
20. Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G (1998) Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 111:3167-3177
21. Hwang SC, Jhon DY, Bae YS, Kim JH, Rhee SG (1996) Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid. J Biol Chem 271:18342-18349
22. Brandt R, Leger J, Lee G (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 131:327-1340
23. Georgieff IS, Liem RK, Couchie D, Mavilia C, Nunez J, Shelanski ML (1993) Expression of high molecular weight tau in the central and peripheral nervous systems. J Cell Sci 105:729-737
24. Pizzi M, Valerio A, Belloni M, Arrighi V, Alberici A, Liberini P, Spano P, Memo M (1995) Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro. Brain Res Mol Brain Res 34(1):38-44